For the Quarter Ending March 2026
Oxytetracycline HCL Prices in North America
- In United States, the Oxytetracycline HCL Price Index rose quarter-over-quarter in Q1 2026, driven by elevated production costs.
- The Oxytetracycline HCL Production Cost Trend increased in March 2026 as the Producer Price Index rose 4.0%.
- Consumer Price Index inflation reached 3.3% in March 2026, which increased freight costs for Oxytetracycline HCL distribution.
- The Oxytetracycline HCL Demand Outlook strengthened in March 2026 because retail sales grew 4.0%, supporting meat consumption.
- In March 2026, a 4.3% unemployment rate and a 91.8 consumer confidence index sustained agricultural antibiotic usage.
- Industrial production grew 0.7% and the Manufacturing Index expanded in March 2026, supporting steady pharmaceutical formulation activity.
- Natural gas energy costs spiked to all-time highs during Winter Storm Fern in January 2026, impacting fermentation.
- Veterinary antibiotic demand strengthened as domestic beef and pork production volumes expanded in January 2026.
- The Oxytetracycline HCL Price Forecast remained elevated in March 2026 following severe winter energy disruptions.
Why did the price of Oxytetracycline HCL change in March 2026 in North America?
- Natural gas energy costs spiked to all-time highs during Winter Storm Fern in January 2026.
- The Producer Price Index rose 4.0% in March 2026, forcing manufacturers to pass on costs.
- Domestic beef and pork production volumes expanded in January 2026, which strengthened veterinary antibiotic demand.
Oxytetracycline HCL Prices in Europe
- In Germany, the Oxytetracycline HCL Price Index rose quarter-over-quarter in Q1 2026, driven by constrained spot availability.
- Inflation at 2.7% increased the Oxytetracycline HCL Production Cost Trend, while producer prices declined 0.2% in March 2026.
- The Manufacturing Index expanded in March 2026; however, 0.0% industrial production in February 2026 flattened the Oxytetracycline HCL Demand Outlook.
- Retail sales grew 0.7% and unemployment stabilized at 4.2% in February 2026, supporting veterinary Oxytetracycline HCL usage.
- Negative consumer confidence at -24.7 in March 2026 reduced discretionary spending on companion animal Oxytetracycline HCL treatments.
- Global soybean meal costs strengthened in Q1 2026, raising essential nitrogen fermentation expenses for Oxytetracycline HCL production.
- Pharmaceutical export volumes from the United States to Germany contracted in February 2026, constraining Oxytetracycline HCL availability.
- The Oxytetracycline HCL Price Forecast remained elevated as natural gas and electricity prices dropped sharply in February 2026.
Why did the price of Oxytetracycline HCL change in March 2026 in Europe?
- Constrained spot availability of imported active pharmaceutical ingredients supported the Oxytetracycline HCL price in Q1 2026.
- Strengthened global soybean meal costs in Q1 2026 increased fermentation expenses for Oxytetracycline HCL production.
- Veterinary pharmaceutical demand strengthened in January 2026, driving upward pressure on the Oxytetracycline HCL price.
Oxytetracycline HCL Prices in APAC
- In China, the Oxytetracycline HCL Price Index rose quarter-over-quarter in Q1 2026 alongside feedstock expenses.
- The Oxytetracycline HCL Production Cost Trend increased in March 2026 as producer prices rose 0.5%.
- The Oxytetracycline HCL Demand Outlook strengthened in March 2026, supported by 1.0% consumer inflation growth.
- Industrial production grew 5.7% and the Manufacturing Index expanded in March 2026, boosting chemical consumption.
- Retail sales grew 1.7% and unemployment reached 5.4% in March 2026, reflecting mixed economic conditions.
- The Oxytetracycline HCL Price Forecast remained elevated in March 2026 despite consumer confidence hitting 90.0.
- Soybean meal fermentation feedstock costs climbed steadily throughout Q1 2026 due to higher freight expenses.
- Pharmaceutical export volumes from China expanded in Q1 2026, driving downstream active pharmaceutical ingredient demand.
Why did the price of Oxytetracycline HCL change in March 2026 in APAC?
- Geopolitical conflicts escalated shipping costs for raw material imports in March 2026, pushing prices upward.
- Raw soybean import volumes into China decreased in February 2026, easing immediate port supply constraints.
- Downstream demand from the animal feed sector remained stable with seasonal procurement in Q1 2026.
For the Quarter Ending December 2025
Oxytetracycline HCL Price in APAC
- In China, the Oxytetracycline HCL Price Index declined quarter-over-quarter in Q4 2025, influenced by weak consumer demand and producer deflation.
- Oxytetracycline HCL production costs decreased in December 2025, as producer prices fell by 1.9% year-over-year.
- Oxytetracycline HCL demand outlook was mixed in Q4 2025, with robust pharmaceutical growth offsetting weakening domestic consumption.
- Persistent structural oversupply in the broader chemical industry impacted Oxytetracycline HCL inventory levels throughout 2025.
- Energy feedstock context in 2025 saw continued coal capacity expansion, influencing industrial production costs.
- The pharmaceutical sector experienced strong growth in 2025, supporting Oxytetracycline HCL demand.
- Weak consumer demand, evidenced by a 0.8% CPI in December 2025, dampened Oxytetracycline HCL veterinary applications.
- Industrial production expanded 5.2% in December 2025, indicating robust activity for API manufacturing.
- China's export volumes redirected from North America to ASEAN, Europe, and Africa in Q4 2025.
Why did the price of Oxytetracycline HCL change in December 2025 in APAC?
- Producer prices declined 1.9% in December 2025, reducing Oxytetracycline HCL production costs.
- Weak consumer demand, with retail sales up 0.9% in December 2025, impacted end-use markets.
- Persistent structural oversupply in the chemical industry throughout 2025 created downward price pressure.
Oxytetracycline HCL Price in North America
- In United States, the Oxytetracycline HCL Price Index rose quarter-over-quarter in Q4 2025, driven by rising production costs and robust demand.
- Production costs increased, influenced by a 2.7% year-over-year CPI rise in December 2025 and strengthening natural gas prices.
- Input costs for manufacturers rose, with the Producer Price Index increasing 3.0% year-over-year in November 2025.
- Demand for Oxytetracycline HCL was robust, supported by a 2.0% year-over-year increase in industrial production in December 2025.
- Strong consumer spending, with retail sales up 3.3% year-over-year in November 2025, bolstered end-use markets.
- The animal health market experienced growth in 2025, driving demand for Oxytetracycline HCL in veterinary applications.
- The pharmaceutical industry outperformed in Q4 2025, indicating sustained demand for active pharmaceutical ingredients.
- Natural gas inventories declined in December 2025 due to robust withdrawals, contributing to higher energy costs.
Why did the price of Oxytetracycline HCL change in December 2025 in North America?
- Production costs rose due to a 3.0% PPI increase in November 2025 and strengthening natural gas prices.
- Demand increased, supported by a 2.0% rise in industrial production in December 2025 and growing animal health markets.
- Supply chain dynamics, including inventory building and trade policy concerns, influenced market stability.
Oxytetracycline HCL Price in Europe
- Germany's Oxytetracycline HCL Price Index fell in Q4 2025, influenced by declining producer input costs and contracting manufacturing activity.
- Oxytetracycline HCL production costs faced upward pressure from surging natural gas feedstock in December 2025 and elevated wholesale electricity.
- Overall producer input costs for industrial products declined 2.5% year-over-year in December 2025, impacting Oxytetracycline HCL manufacturing.
- Demand for Oxytetracycline HCL faced headwinds as the Manufacturing Index contracted in December 2025, reflecting economic slowdown.
- Consumer confidence remained significantly negative at -17.5 in December 2025, indicating potential weakening demand.
- The unemployment rate stood at 6.2% in December 2025, suggesting economic slack dampening Oxytetracycline HCL demand.
- Pharmaceutical demand in Germany was consistently propelled by an aging population and high-value therapies in Q4 2025.
- General inflation, with CPI at 1.8% year-over-year in December 2025, increased operational costs for Oxytetracycline HCL manufacturers.
- Industrial production grew 0.8% in October 2025, and retail sales increased 1.1% in November 2025, offering some economic support.
Why did the price of Oxytetracycline HCL change in December 2025 in Europe?
- Producer input costs declined 2.5% year-over-year in December 2025, reducing Oxytetracycline HCL manufacturing expenses.
- Natural gas feedstock costs surged in December 2025, while wholesale electricity prices remained elevated.
- Contracting manufacturing activity and negative consumer confidence in December 2025 dampened overall demand.
For the Quarter Ending September 2025
Oxytetracycline HCL Prices in North America
- In United States, the Oxytetracycline HCL Price Index rose quarter-over-quarter in Q3 2025, driven by increasing production costs.
- Oxytetracycline HCL production costs increased due to a 3.0% CPI rise in September 2025 and 2.6% PPI rise in August 2025.
- Demand outlook for Oxytetracycline HCL was mixed, with strengthening animal healthcare demand in Q3 2025.
- Retail sales increased 5.42% year-over-year in September 2025, supporting demand for animal products.
- US natural gas prices experienced an uptick in Q3 2025, and retail electricity prices increased in September 2025.
- The broader US chemical industry experienced an oversupply situation in Q3 2025, impacting market dynamics.
- Industrial production grew 0.1% year-over-year in September 2025, alongside declining consumer confidence to 94.2.
- Net farm income is projected to increase in 2025, while broiler production increased in Q3 2025.
Why did the price of Oxytetracycline HCL change in September 2025 in North America?
- Production costs rose due to a 3.0% CPI increase in September 2025 and higher energy prices.
- Strong retail sales, up 5.42% year-over-year in September 2025, supported demand for animal products.
- An oversupply in the broader US chemical industry in Q3 2025 exerted downward pressure.
Oxytetracycline HCL Prices in APAC
- In China, the Oxytetracycline HCL Price Index fell in Q3 2025, influenced by weak industrial demand and pricing pressure.
- Oxytetracycline HCL production costs increased in August 2025, driven by higher corn futures and unusually low corn imports.
- The Oxytetracycline HCL demand outlook was challenged in Q3 2025 by slow agricultural product consumption and decreased beef/dairy.
- China's Manufacturing Index contracted in September 2025, indicating a slowdown in industrial activity affecting Oxytetracycline HCL demand.
- Industrial production rose 6.5% year-on-year in September 2025, suggesting robust activity in Oxytetracycline HCL consuming sectors.
- The Producer Price Index (PPI) fell 2.3% year-on-year in September 2025, reflecting weak industrial demand.
- China's chemical industry experienced significant overcapacity in 2025, contributing to downward pressure on Oxytetracycline HCL prices.
- Retail sales grew 3.0% year-on-year in September 2025, supporting consumer demand for animal products and veterinary medicine.
Why did the price of Oxytetracycline HCL change in September 2025 in APAC?
- Weak industrial demand, with PPI falling 2.3% year-on-year, pressured Oxytetracycline HCL prices.
- Contracting Manufacturing Index in September 2025 reduced industrial activity, lowering Oxytetracycline HCL demand.
- Chemical industry overcapacity in China during 2025 contributed to downward Oxytetracycline HCL pricing pressure.
Oxytetracycline HCL Prices in Europe
- In Germany, the Oxytetracycline HCL Price Index fell quarter-over-quarter in Q3 2025, influenced by contracting industrial activity and easing production costs.
- Oxytetracycline HCL production costs eased in Q3 2025, driven by declining hydrochloric acid and moderated ammonium sulfate costs.
- Despite a 2.4% CPI increase in September 2025, producer input costs were influenced by a -1.7% PPI decline.
- Demand for Oxytetracycline HCL faced headwinds in Q3 2025 from a contracting Manufacturing Index and 1.0% industrial production decline.
- Pessimistic consumer confidence at -23.6 in September 2025 indirectly dampened demand for veterinary Oxytetracycline HCL.
- A low 3.9% unemployment rate and 0.8% retail sales growth in September 2025 provided some indirect support.
- Steady growth in the German animal health market in Q3 2025, driven by rising preventive care demand, supported veterinary Oxytetracycline HCL.
- Subdued export performance for Germany's chemical industry in Q3 2025 limited trade opportunities for Oxytetracycline HCL.
Why did the price of Oxytetracycline HCL change in September 2025 in Europe?
- Contracting industrial activity in September 2025, shown by a declining Manufacturing Index, reduced Oxytetracycline HCL demand.
- Producer input costs eased in September 2025, with a -1.7% PPI decline and lower hydrochloric acid prices.
- Pessimistic consumer confidence at -23.6 in September 2025 indirectly dampened Oxytetracycline HCL demand.
